Lipolysis in rat adipose tissue in vitro and its alpha 2 adrenergic control.
Although the alpha 2-adrenergic inhibitory control on lipolysis in several mammalian species, e.g. in dogs, hamsters, rabbits and also in man has been proved recently, in rats some peculiarities have been described in the alpha-adrenergic regulation of lipid mobilization. In the present study the effect of the specific alpha 2-adrenergic blocking agent--yohimbine (YOH)--on lipid mobilization in young (45-55 days old) and old (6 months) rats of the Wistar strain was followed and also its interaction with the beta-adrenergic blocking agent propranolol and the specific alpha 2-adrenergic agonist--clonidine. Furthermore, the effect of YOH on the isoprenaline (ISO) induced lipolysis was studied. The adipokinetic effect was estimated from the amount of released non-esterified fatty acids from the tissue preparation into the incubation medium. In all experimental series YOH produced a significant response, which was concentration-dependent (pD2 6.2) with the maximum effect corresponding to 40% of the highest adipokinetic action of ISO. Young rats were more sensitive than old animals. In both age groups YOH non-competitively decreased the highest effect of ISO to the level of its own lipid-mobilizing activity. In the presence of YOH, the ISO dose-response curve therefore completely disappears. The adipokinetic effect of YOH can be antagonized competitively by clonidine (CLO) (pA2 6.25 and 6.01 for concentrations of CLO 1 and 10 mumol.1(-1) respectively). The inhibitory effect of propranolol is about two orders lower. It is concluded that in rats the alpha 2-adrenergic control rather concerns basal lipolysis, whereas induced lipid mobilization can be inhibited by depression of the alpha 2-activity.
D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D003000:Clonidine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004822:Epididymis; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D015016:Yohimbine / Q000494:pharmacology
D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D011433:Propranolol; D007545:Isoproterenol; D003000:Clonidine